Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

420 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Asymptomatic Waldenstrom's macroglobulinemia.
Alexanian R, Weber D, Delasalle K, Cabanillas F, Dimopoulos M. Alexanian R, et al. Among authors: cabanillas f. Semin Oncol. 2003 Apr;30(2):206-10. doi: 10.1053/sonc.2003.50051. Semin Oncol. 2003. PMID: 12720137
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.
Wang M, Fayad L, Wagner-Bartak N, Zhang L, Hagemeister F, Neelapu SS, Samaniego F, McLaughlin P, Fanale M, Younes A, Cabanillas F, Fowler N, Newberry KJ, Sun L, Young KH, Champlin R, Kwak L, Feng L, Badillo M, Bejarano M, Hartig K, Chen W, Chen Y, Byrne C, Bell N, Zeldis J, Romaguera J. Wang M, et al. Among authors: cabanillas f. Lancet Oncol. 2012 Jul;13(7):716-23. doi: 10.1016/S1470-2045(12)70200-0. Epub 2012 Jun 6. Lancet Oncol. 2012. PMID: 22677155 Clinical Trial.
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
Chen Y, Neelapu S, Feng L, Bi W, Yang TH, Wang M, Fanale MA, Westin JR, Hagemeister FB, Fayad LE, Romaguera JE, Samaniego F, Turturro F, Fowler NH, McLaughlin P, Cabanillas F, Oki Y, Nastoupil LJ, Rodriguez A. Chen Y, et al. Among authors: cabanillas f. Br J Haematol. 2016 Oct;175(2):290-299. doi: 10.1111/bjh.14237. Epub 2016 Jul 22. Br J Haematol. 2016. PMID: 27448187
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.
Ha CS, Cabanillas F, Lee MS, Tucker SL, McLaughlin P, Rodriguez MA, Younes A, Romaguera JE, Mesina OM, Cox JD. Ha CS, et al. Among authors: cabanillas f. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):188-93. doi: 10.1016/j.ijrobp.2005.01.027. Int J Radiat Oncol Biol Phys. 2005. PMID: 16111588 Clinical Trial.
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Rassidakis GZ, Medeiros LJ, McDonnell TJ, Viviani S, Bonfante V, Nadali G, Vassilakopoulos TP, Giardini R, Chilosi M, Kittas C, Gianni AM, Bonadonna G, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH. Rassidakis GZ, et al. Among authors: cabanillas f. Clin Cancer Res. 2002 Feb;8(2):488-93. Clin Cancer Res. 2002. PMID: 11839668
Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas.
Shah N, Cabanillas F, McIntyre B, Feng L, McLaughlin P, Rodriguez MA, Romaguera J, Younes A, Hagemeister FB, Kwak L, Fayad L. Shah N, et al. Among authors: cabanillas f. Leuk Lymphoma. 2012 Jan;53(1):50-6. doi: 10.3109/10428194.2011.616611. Epub 2011 Oct 24. Leuk Lymphoma. 2012. PMID: 21895545 Free PMC article.
Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone.
Sarris AH, Jiang Y, Tsimberidou AM, Thomaides A, Rassidakis GZ, Ford RJ, Medeiros LJ, Cabanillas F, McLaughlin P. Sarris AH, et al. Among authors: cabanillas f. Semin Oncol. 2002 Feb;29(1S2):48-55. doi: 10.1053/sonc.2002.30144. Semin Oncol. 2002. PMID: 28140092
Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.
Romaguera JE, Fayad LE, Feng L, Hartig K, Weaver P, Rodriguez MA, Hagemeister FB, Pro B, McLaughlin P, Younes A, Samaniego F, Goy A, Cabanillas F, Kantarjian H, Kwak L, Wang M. Romaguera JE, et al. Among authors: cabanillas f. Br J Haematol. 2010 Jul;150(2):200-8. doi: 10.1111/j.1365-2141.2010.08228.x. Epub 2010 May 26. Br J Haematol. 2010. PMID: 20528872 Review.
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Wang M, Fayad L, Cabanillas F, Hagemeister F, McLaughlin P, Rodriguez MA, Kwak LW, Zhou Y, Kantarjian H, Romaguera J. Wang M, et al. Among authors: cabanillas f. Cancer. 2008 Nov 15;113(10):2734-41. doi: 10.1002/cncr.23880. Cancer. 2008. PMID: 18973182 Clinical Trial.
Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma.
Berrios-Rivera JP, Fang S, Cabanillas ME, Cabanillas F, Lu H, Du XL. Berrios-Rivera JP, et al. Among authors: cabanillas me, cabanillas f. Am J Clin Oncol. 2007 Apr;30(2):163-71. doi: 10.1097/01.coc.0000251356.63237.4f. Am J Clin Oncol. 2007. PMID: 17414466 Clinical Trial.
420 results
Jump to page
Feedback